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Abstract 
The ion transfer of a series of ionised 14- and 15-membered macrolide compounds across polarised 
water/nitrobenzene have been studied by cyclic voltammetry. Fourteen-membered macrolides transfer as 
singly-charged molecules in the wide pH range, while 15-membered macrolides can transfer as both singly 
and doubly protonated cations, depending on the pH of the aqueous solution. The results showed that the 
formal transfer potentials ( 0'wo i  ) of the investigated compounds varied to a great extent and that 
minor changes in macrolide structure caused significant change in the corresponding formal transfer 
potentials. Among the investigated macrolides, azithromycin had the lowest formal transfer potential and 
its peculiar ADME behaviour is ascribed to this specific property. 
Keywords: azithromycin; erythromycin; oleandomycin; clarithromycin; liquid/liquid interface; cyclic 
voltammetry; pharmacokinetics; lipophilicity; ADME 
 
Introduction 
Macrolides are a class of compounds that exert antibiotic activity against most Gram-positive bacteria 
and several Gram-negative respiratory and enteric pathogens [1-4]. The main building block common to all 
macrolides is a large and highly substituted 14-, 15- or 16-membered macrolactone ring on which one to 
three sugar moieties such as cladinose and desosamine are usually attached. The mechanism of action of 
macrolides is the inhibition of RNA-directed protein synthesis, usually achieved by binding to the 50S 
subunit of bacterial ribosomes [5,6]. 
Erythromycin (1) is a naturally occurring compound first isolated from the Saccharopolyspora erythraea, 
microorganism found in Philippine soil (Figure 1). It is the prototype 14-membered macrolide compound 
and almost all other 14- and 15-membered macrolides are semi-synthetic derivatives of erythromycin. The 
expansion of the erythromycin ring by insertion of nitrogen into the 9a position leads to the 15-membered 
class of macrolides, widely known as azalides [7]. The most potent and widely prescribed antibiotic 
belonging to this class is azithromycin (2) (Figure 1). In addition to its broad antibiotic spectrum against 
Gram-positive bacteria, azithromycin has proven useful in the treatment of some Gram-negative 
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respiratory pathogens such as Haemophilus influenza, as well as enterobacteria such as Salmonella [1,2,8-
10]. 
Macrolide pharmacokinetics differs from other antibiotics. They are able to penetrate a variety of cells 
and can achieve high intracellular concentrations. This includes increased accumulation in 
polymorphonuclear cells (PMN) and macrophages, which tend to concentrate at the infection sites, 
resulting in targeted drug delivery systems [4]. Although all macrolides show similar ADME properties and 
pharmacokinetics, azithromycin stands out due to its enhanced antimicrobial activity, a more favourable 
adverse reaction profile and improved pharmacokinetic properties. Azithromycin concentrations are more 
than 200 times higher intracellularly than extracellularly [4], resulting in the extended exposure of 
phagocytes and other cells to the drug. It has been found that in the presence of bacteria in the 
extracellular medium, a rapid release of azithromycin from phagocytes occurs. As an additional advantage, 
azithromycin retains high and prolonged tissue levels, ensuring that pathogens are continuously exposed to 
high bactericidal effects [4]. As a result, azithromycin needs significantly shorter administration time and 
also shows better tolerance to treatment in patients [3]. 
Such peculiar pharmacokinetics of macrolides, especially the high uptake of azithromycin in PMN and its 
fast release at the site of infection, is obviously connected with easy and unhindered membrane transport. 
In several cases, it has been proven that azithromycin transport was governed by pH differences on both 
sides of the membranes and that minor changes in the macrolide structure considerably altered their 
properties, as well as their in vivo availability [4]. The mechanism of macrolide transport is still unclear and 
the question remains whether the transport of macrolides through biological membranes is governed by 
active or passive process [4]. Some evidence indicates the simultaneous coexistence of both mechanisms. 
Both in vivo and in vitro results demonstrate unequal macrolide distribution at different biological 
membranes; therefore, it seems that the pH-partition hypothesis is not the only factor determining their 
pharmacokinetic profiles.  
Almost all macrolides are weak bases due to the presence of tertiary amine nitrogen at the desosamine 
sugar (Fig. 1). In addition, azalides possess another amine group as part of macrolactone ring. Due to the 
pKa values of these amine groups (pKa1 ~ 8.7 and pKa2 ~ 9.3), macrolides exist as charged species in the 
physiological and acidic pH ranges, either as mono-protonated (14-membered macrolides) or doubly 
protonated (azalides) forms. These properties may indicate that the uptake of macrolides is an 
electrochemical potential driven process, and that the electrical potential difference through biological 
membranes may be responsible for governing the overall mechanism of macrolide transport. If this is the 
case, the uptake of macrolides will depend on actual membrane potential, standard transfer potential at 
the membrane/water interface and the difference between them.  
In order to do in vitro testing and determine whether membrane electrical potential plays an important 
role in macrolide pharmacology, an appropriate interface model mimicking the in vivo membrane 
environment must be designed. It has already been proven that liquid/liquid interfaces formed between 
two immiscible liquids, such as water and an appropriate organic solvent, can be used as a model of 
biological membrane [11,12]. In such cases, a tested compound is dissolved in the system and the interface 
is electrochemically polarised, resulting in an ionic species transfer across the interface and its 
redistribution within the two phases. From such measurements, the transfer ability of a compound 
between two phases is represented by a physico-chemical parameter referred to as standard transfer 
potential,  0, which can be easily determined using electrochemical measurements. The standard 
transfer potential of the particular compound is the interfacial potential difference, which will yield equal 
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compound activities in both phases [13]. Consequently, the distribution of charged species between two 
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where   
   is potential difference between two phases,   
   
  and   
   
   are standard transfer potential 
and formal transfer potential, respectively, of the ionised compound i at the organic solvent/water 
interface, a and c are activity and concentration of the ionised compound in the corresponding solvent, 
respectively, and R,T,z and F have their usual thermodynamic meaning.  
Solvents having acceptable dielectric constants for dissolving electrolytes suitable for electrochemical 
measurements and which are usually used for mimicking biological membranes in electrochemistry are 
nitrobenzene and 1,2-dichloroethane. Both solvents have properties similar to those of biological 
membranes and relatively high dielectric constants to enable sufficient dissolution of inert electrolytes, and 
to ensure electric conductivity suitable for performing the electrochemical measurements at their interface 
with aqueous phase. The interfaces nitrobenzene/water, as well as 1,2-dichloroethane/water are good 
models for biological membranes, since they enable the rapid and precise determination of the 
electrochemical properties of ionised biological molecules. Both interfaces have already been used to 
probe the transfer of ionic drug compounds [14-18].  
In the present work, we investigated the electrochemical properties of a series of macrolide compounds 
at the nitrobenzene/water interface. The structures of the investigated compounds are shown in the Fig.1. 
The objectives were to measure the standard transfer potentials of macrolide compounds, to determine 
the mechanisms of their transport at the interface, and to provide some evidence on the importance of in 
vivo membrane electrical potential on the pharmacokinetics of macrolides. The value of standard transfer 
potential  is correlated with the free energy of transfer of ionized species, ΔG=-zFΔφ. Lower the absolute 
value of standard transfer potential of the molecule becomes, higher is its negative free energy, and the 
molecule crosses the interface easier.  
 
Experimental  
Erythromycin (1), clarithromycin (3) and oleandomycin (9) were purchased from Aldrich.  
Azithromycin (2) was obtained from PLIVA d.d. as dihydrate, a 3-decladynosil derivative of azithromycin 
(4) 9a-aza-9-deoxo-9-dihydro-9a-homoerythromycin A (DHL) (5) and its 3-decladinosyl derivative (6), 3’-N-
demetyl-N-methyl-9a-aza-9-deoxo-9-dihydro-9a-homoerythromycin A (7), 3’-N-demetyl-9a-aza-9-deoxo-9-
dihydro-9a-homoerythromycin A (8) were synthesised in PLIVA d.d. from azithromycin as a starting 
compound, according to the procedure described previously [7], and with a purity higher than 95 % as 
determined by HPLC analysis. 
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5: R1=H; R2=CH3; R3=Cld
6: R1=H; R2=CH3; R3=H
7: R1=CH3; R2=H; R3=Cld
8: R1=R2=H; R3=Cld
 




Figure 1: The structures of antibiotics investigated in this work: erythromycin (1), azithromycin (2), clarithromycin (3), 
decladinosil derivative of azithromycin (4), DHL (5), decladinosil derivative of DHL (6), 3’-N-demethylated derivative of 
azithromycin (7), 3’-N-demethylated derivative of DHL (8), oleandomycin (9).  
 
The transfer of ionised antibiotics was studied using cyclic voltammetry at the water/nitrobenzene 
interface and with an interfacial area of 0.12 cm
2
. The investigated antibiotics were dissolved in a aqueous 
phase that consisted of a Britton-Robinson buffer of varying pH. The concentration of antibiotics was 2 
mM. Tetrabutylammonium tetraphenylborate (Bu4NPh4B) was used as a supporting electrolyte in the 
nitrobenzene phase. The cell can schematically be shown as: 
 
Ag/AgCl (0.1 M LiCl) 0.1 M BR buffer, 
Varying pH 
0.05 M Bu4NBPh4 0.1 M Bu4NCl 
AgCl/Ag 
(aqueous phase) (aqueous phase) (nitrobenzene) (aqueous phase) 
 
Four electrode potentiostat (PAR M263A) with positive feedback IR compensation was used for 
performing electrochemical measurements. A platinum sheet and Ag/AgCl electrode served in each phase 
as counter and reference electrodes, respectively. The silver wire for the nitrobenzene solution was 
immersed in a 0.1 M aqueous solution of tetrabutylammonium chloride (Bu4NCl).  
Formal transfer potentials of the investigated antibiotics were determined by measuring their half-wave 
potentials, . The experimentally obtained values were transposed to the Galvani potential scale by 
measuring the half-wave potential of tetramethylammonium ion (Me4N
+), for which absolute Galvani 
potential at water/nitrobenzene is known [19]. All potentials quoted in this paper are potentials of 
aqueous phase with respect to the nitrobenzene phase.  
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Ionization constants, pKa, and log P values were determined by potentiometric titration method (Sirius 
analytical, GLpKa). All measurements were carried out at constant temperature of 25 °C, constant ionic 
strength of 0.15 M KCl and with continuous flow of argon to prevent the absorption of CO2 from the 
atmosphere. The pH-electrode was standardized using Sirius Four-PlusTM procedure. 
Results and Discussion 
Electrochemical properties of the investigated macrolides and their distribution at water/nitrobenzene 
interface depend on their pH dependent speciation. Fourteen-membered macrolides, such as erythromycin 
(1) and clarithromycin (3) possess a tertiary amine group with a pKa value of 9.3 ± 0.05, making this class of 
macrolides weak bases existing as singly charged forms in a neutral and acidic pH range. Macrocyclic amine 
groups of azalides introduce additional nitrogen into 15-membered macrolides with an ionisation constant 
measured to be around pKa=8.7. Since these ionisation constants present global values and no micro-
ionisation data were available in the literature, the exact speciation of the azalide antibiotics, especially in 
a slightly basic solution, is impossible to discern.  
Transfer properties of the investigated macrolides, as well as their formal transfer potentials, were 
investigated by cyclic voltammetry as a function of aqueous pH. As was expected, the results could be 
grouped into two categories, depending on the number of basic nitrogen atoms in the molecule.  





















Figure 2: Cyclic voltammograms of erythromycin and azithromycin at a pH of aqueous phase 5.8. Scan rate: 20 mV/s. 
 
The comparison of the cyclic voltammograms of azithromycin and erythromycin taken at aqueous phase 
pH=5.8, where both compounds exist in fully protonated forms, is shown in Fig. 2. Only one reversible, 
diffusion-controlled wave was observed for each compound at this pH value. In an anodic potential 
direction, a transfer of protonated forms from the aqueous to nitrobenzene phase took place, giving rise to 
positive currents, while negative currents in the cathodic potential sweep represented the transfer of the 
same species back from the nitrobenzene to aqueous phase. The linearity of the current peak height with 
the square root of the scan rate revealed diffusion control of the transfer process. It was found that 
diffusion coefficients calculated using Randles-Ševčik equation depended on the actual pH of the aqueous 
phase. For azithromycin diffusion coefficients in aqueous phase ranged from 1.3 x 10-5 cm2 s-1 at pH 2 to  
6.8 x 10-6 cm2 s-1 at pH 8.6. This can be explained by the complex equilibrium of ionized species at the 
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interface as already described by Velický et al. [20]. No kinetically slow steps were detected in the cyclic 
voltammograms. Anodic and cathodic current peak separations being close to 30 and 60 mV for 
azithromycin and erythromycin, respectively, confirmed doubly-protonated azithromycin and singly-
protonated erythromycin to be the predominant species at acidic pHs and were involved in the interfacial 
transfer reactions: 
AzH2
2+(w)        AzH2
2+(NB)       (2) 
ErH+(w)        ErH+(NB) (3) 
The half-wave potentials determined by these measurements were related to the formal transfer 
potentials of monoprotonated erythromycin molecules and diprotonated azithromycin molecules 










     (4) 
where  and  are diffusion coefficients of transferring species in nitrobenzene and aqueous phases, 
respectively. Using equation (4), the formal transfer potentials of erythromycin and azithromycin were 
calculated assuming the proportionality of diffusion coefficients with the viscosities of water and 
nitrobenzene (Walden rule). They amounted to 0'wo ErH  = -58 mV and 22
0'w
o AzH
  = -46 mV for erythromycin 
and azithromycin, respectively.  
No changes in the cyclic voltammograms of azithromycin and erythromycin were observed in the pH 
range 2-6. Above pH 6, cyclic voltammograms for erythromycin shifted toward more positive potentials 
with a slope close to 60 mV/pH, while retaining its shape and reversibility. However, the electrochemical 
behaviour of azithromycin proved more complex. Between pH 6-7, a second current wave appeared at 
more positive potentials, whereas the height of the first wave decreased (Fig. 3a). Above pH 7.5, the first 
current wave completely disappeared and the second wave shifted toward more positive potentials (Fig. 
3b), with the slope varying from 30 to 60 mV/pH (Figure 4).  





















Figure 3. Cyclic voltammograms of azithromycin at various aqueous phase pH. Actual pHs indicated on the graphs. 
Scan rate = 20 mV/s.  
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Figure 4: pH dependence of the transfer potentials of erythromycin (squares) and azithromycin (circles).  
 
These results indicate that in contrast to erythromycin molecules, the mechanism of azithromycin 
transfer changed when moving from an acidic towards a basic solution. It appears reasonable to assume 
that when aqueous solution pH approaches the neutral and slightly basic region, azithromycin will start to 
deprotonate and as neutral molecules redistribute between the two phases. In such a case, a neutral form 
of azithromycin will be transferred to nitrobenzene as a potentially independent process and will act as a 
protonophore, facilitating proton transfer from the aqueous to nitrobenzene phase according to the 
equation (5): 
 
Az(NB)  +  H+(w)        AzH+(NB) (5) 
 
The anodic and cathodic peak separation in basic solutions is around 60 mV indicating the transfer of 
singly protonated species. Taking into account two protonation sites of azithromycin, with global pKa 
values similar to one another (ΔpKa ~ 0.5), it is possible for both monoprotonated azithromycin 
microspecies to transfer simultaneously from aqueous to nitrobenzene phase within the investigated pH 
range. Lipophilicities of both protonated micro-forms are expected to be the same, since no evidence could 
be found in the literature of the potential conformational changes induced by the positive charge on either 
protonation site of the azithromycin molecule. Consequently, the transfer potentials of these two mono-
protonated species should not differ by a considerable amount and could not be discerned in the cyclic 
voltammetry measurements. 
Formal transfer potential of the mono-protonated azithromycin molecule can be estimated using the 
extrapolation of 1/2
w
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where log NBAzP  is the partition coefficient between water and nitrobenzene and 
w
apK  is the ionisation 
constant of mono-protonated azithromycin in water. From the experimental points indicated in Fig. 4 and 
approximating log NBAzP  to the known partition coefficient of azithromycin in octanol, log
Oct
AzP , the value of 
the formal transfer potential of mono-protonated azithromycin was calculated to 0'wo AzH   = -130 mV. 
The two macrolides described above, erythromycin and azithromycin, are prototype compounds 
representing 14- and 15-membered macrolides. All other investigated macrolides showed electrochemical 
behaviour similar to either one of these two compounds, depending on which class of macrolides they 
belonged to: 14-membered macrolides with one protonation site or 15-membered macrolides with two 
protonation sites. Thus, clarithromycin (3) and oleandomycin (9) exhibited one reversible current wave, 
representing the transfer of their protonated forms and the behaviour of other five azalide compounds, 
while 4-8 was consistent with the azithromycin transfer exhibiting two different types of transfer 
mechanism. However, the formal transfer potentials among these compounds vary, indicating that 
different energies are involved in the transfer processes. The values of formal transfer potentials, 0'wo i , 
for mono-protonated 14-membered macrolides and for both mono- and di-protonated azalides are shown 
in Table 1.  
Table 1: Formal transfer potentials of investigated compounds. 
Macrolides log P 
0'w




azithromycin, 2 3.98 -130* -46 
DHL, 5 3.63 -90* -4 
3’-N-demethyl 
azithromycin, 7 
3.62 -90* -5 
3’-N-demethyl DHL, 8 3.45 -60* +24 
3-decladinosil 
azithromycin, 4  
3.11 -65* +18 
3-decladinosil DHL, 6 3.03 -35* +45 
14-
membered 
erythromycin, 1 3.02 -58 - 
claritromycin, 3 3.24 < -100 - 
oleandomycin, 9 2.76 -48 - 
*Calculated by equation (6) with the assumption of equal water/nitrobenzene and water/octanol partition coefficients 
and with pKa=9 as the average value of two ionisation constants. 
 
Macrolides' ability to pass through biological membranes and to accumulate in high concentrations 
intracellularly are of paramount importance for their pharmacokinetics, as proven by the significant 
amount of in vivo and in vitro data accumulated on the subject over the years [4]. In order to reach the site 
of the infection, macrolides have to cross biological membranes several times. Upon administration, 
macrolides dissolve in the stomach due to the environment's favourable pH value (pH = 1-2) for the 
dissolution of weak bases. After passage of macrolides into the duodenum and further to the jejunum, 
where pH microclimates range from 5-7 [23], macrolides still predominantly remain in their charged state. 
From there, they are able to enter the bloodstream by passive diffusion, either transcellularly through the 
bilayer surface of epithelial cells or paracellularly. Both neutral and charged forms can participate in 
Z. Mandić  ADMET & DMPK 2(3) (2014) 168-178 
176  
passive diffusion. Neutral forms can distribute according to the pH-partition hypothesis, while charged 
molecules can distribute according to the difference between the actual membrane potential and their 
formal transfer potential 0'wo i , as predicted by equation (1).  
It is assumed that weak bases such as macrolides are concentrated in the more acidic parts of 
membranes. This behaviour has already been experimentally observed several times in vivo [4] and was 
found to be the key process determining macrolide pharmacokinetics. However, it remains puzzling as to 
why azithromycin, compared to other macrolides, can achieve and retain very high (up to 200 times) 
intracellular concentrations, especially within polymorphonuclear cells such as neutrophils. Being highly 
motile, neutrophils are quickly attracted to the site of an infection, where azithromycin is rapidly released. 
The whole system represents a very efficient drug delivery system. Consequently, azithromycin is 
administered in patients in single daily doses during no more than two to three days. This is highly 
advantageous compared to treatment with other macrolides such as erythromycin and clarithromycin, 
which might achieve similar remedial effects only after a week or 10 days when administered in double or 
triple daily doses.  
High azithromycin accumulation might be partially the result of the involvement of active 
transmembrane transport, but it nonetheless seems plausible to assume that transmembrane electrical 
potential is the key factor in macrolide pharmacokinetics. Indeed, when the data given in Table 1 are 
analysed, it turns out that azithromycin has the lowest formal transfer potential among the investigated 
macrolide compounds. 0'wo i of a singly-charged molecule of azithromycin, AzH
+, is -130 mV and even 72 
and 82 mV lower than 14-membered mono-protonated erythromycin and oleandomycin, respectively. The 
lowest 0'wo i means that charged azithromycin has the lowest free energy of transfer to and through the 
membrane. Although the situation at the biological membrane is more complex due to the involvement of 
the two membrane interfaces with two membrane/water potential differences, the concept of the 
distribution of the charged molecules on both sides of the membrane remains valid and follows the 
equilibrium given by equation 1. Depending on the difference between standard (or formal) transfer 
potential and the actual membrane potential, the distribution of different molecules at both sides of the 
membrane might vary to a significant extent.  
It is worth noting here that the treatment of neuthrophiles with ionophores such as gramicidin resulted 
in the reduction of azithromycin uptake in neutrophils [24]. Ionophores increase the permeability of 
biological membranes to the ionic species dissipating their concentration gradients and consequently 
reducing the transmembrane electrical gradient. Although decreased uptake of azithromycin in gramicidin 
treated neutrophils might be the result of the levelling off pH gradient across the membrane, it might point 
out also to the importance of the membrane potential on the pharmacokinetics of azithromycin [24]. 
A comparison of azithromycin to other investigated azalides highlights the importance of tertiary amine 
groups in the transfer process. The results were consistent with earlier observations that minor changes in 
the macrolide structure significantly affected their chemical and biological properties.  
The favourable influence of the two methyl groups and cladinose sugar moiety on the lipophilic and 
pharmacokinetic behaviour of azithromycin was demonstrated by the increase of the formal transfer 
potentials after their elimination from the macrolide scaffold. Each methyl group on the amine contributed 
about 3.9 kJ mol-1 and cladinose sugar even with 6.3 kJ mol-1 in lowering free energy of transfer of 
azithromycin. This could not be explained by their more lipophilic contribution to the overall lipophilicity of 
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the azithromycin, at least, not in a significant extent. It is more likely that outstanding membrane transfer 
properties of azithromycin are connected to its ability to form two conformations, referred to as folded-in 
and folded-out conformations [25,26]. The fraction of each conformation depends on the polarity of its 
environment and it is possible that azithromycin undergoes conformational change after having been 
transferred from one phase into another.  
 
Conclusions 
Cyclic voltammetry at the water/nitrobenzene interface has been demonstrated as an important 
technique for evaluating the influence of the relevant physico-chemical property, 0'wo i , as it concerns the 
pharmacokinetics of macrolides. All macrolides studied in this paper transferred from the aqueous to the 
nitrobenzene phase at a sufficiently high interfacial potential. Half-wave potential of the 14-membered 
macrolides shifted toward more positive potentials by 60 mV/pH, while 15-membered azalide compounds 
exhibited more complex behaviour. Above pH 7, two mono-protonated species were involved in the 
transfer.  
Azithromycin exhibited the lowest standard transfer potential among all macrolides, which is consistent 
with its outstanding in vivo behaviour and exceptional pharmacokinetics.  
These results show that cyclic voltammetry can be used in pharmaceutical research and development as a 
fast and simple method for screening out macrolide compounds with potentially good ADME properties.  
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